Skip to main content
SpringerLink
Log in
Book cover

Gastric Cancer: the 25-year R-Evolution pp 259–265Cite as

Long-Term Survival and Follow-Up After Gastrectomy for Cancer

  • Chapter
  • First Online:

  • 740 Accesses

Part of the book series: Updates in Surgery ((UPDATESSURG))

Abstract

According to the Charter Scaligero—a consensus paper produced in 2013 in Verona during the 10th International Gastric Cancer Congress—clinical and imaging follow-up is usually provided to patients treated with radical intent, even in the absence of good quality evidence of a survival improvement. Thanks to regular follow-up, however, data on survival are available. Early gastric cancers (EGC) suitable for endoscopic treatment have a good prognosis with survival rates close to 100%. Patients with EGC who have risk factors for lymph node metastases after endoscopic resections or not meeting the criteria for endoscopic treatment must undergo surgery. In these cases, adequate lymphadenectomy offers a high probability of cure with successful survival (>90% 5-year disease-free survival). Submucosal invasion, Laurén diffuse/mixed type, Kodama Pen A type and tumor size are associated with an increased risk of lymph node metastases even in EGC. Advanced gastric cancers should undergo gastrectomy and standard D2 lymphadenectomy, if necessary combined with perioperative chemotherapy. Five-year overall survival for stage II and III range from 44% to 86% and from 22% to 64%, respectively. Finally, the survival of stage IV patients remains poor. Chemotherapy is the treatment of choice and the role of surgery is limited to palliation of symptoms and to selected cases of oligometastatic disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Whiting J, Sano T, Saka M, et al. Follow-up of gastric cancer: a review. Gastric Cancer. 2006;9(2):74–81.

    Article  Google Scholar 

  2. Cardoso R, Coburn NG, Seevaratnam R, et al. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer. 2012;15(Suppl 1):S164–7.

    Article  Google Scholar 

  3. Marrelli D, Morgagni P, de Manzoni G, et al. External validation of a score predictive of recurrence after radical surgery for non-cardia gastric cancer: results of a follow-up study. J Am Coll Surg. 2015;221(2):280–90.

    Article  Google Scholar 

  4. Baiocchi GL, Marrelli D, Verlato G, et al. Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer. Ann Surg Oncol. 2014;21(6):2005–11.

    PubMed  Google Scholar 

  5. Baiocchi GL, Kodera Y, Marrelli D, et al. Follow-up after gastrectomy for cancer: results of an international web round table. World J Gastroenterol. 2014;20(34):11966–71.

    Article  Google Scholar 

  6. Baiocchi GL, D’Ugo D, Coit D, et al. Follow-up after gastrectomy for cancer: the charter Scaligero consensus conference. Gastric Cancer. 2016;19(1):15–20.

    Article  Google Scholar 

  7. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.

    Article  Google Scholar 

  8. Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10(1):1–11.

    Article  Google Scholar 

  9. Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198–205.

    Article  Google Scholar 

  10. Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101(2):23–31.

    CAS  PubMed  Google Scholar 

  11. Folli S, Morgagni P, Roviello F, et al. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol. 2001;31(10):495–9.

    Article  CAS  Google Scholar 

  12. de Manzoni G, Marrelli D, Baiocchi GL, et al. The Italian research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2017;20(1):20–30.

    Article  Google Scholar 

  13. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.

    Article  Google Scholar 

  14. Reddavid R, Sofia S, Chiaro P, et al. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol. 2018;24(2):274–89.

    Article  Google Scholar 

  15. Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–57.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, San Luigi University Hospital, University of Turin, Orbassano (Turin), Italy

    Maurizio Degiuli, Lucia Puca & Rossella Reddavid

  2. Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

    Gian Luca Baiocchi

  3. Division of General Surgery, ASST Cremona, Cremona, Italy

    Gian Luca Baiocchi

Authors
  1. Maurizio Degiuli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gian Luca Baiocchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucia Puca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rossella Reddavid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maurizio Degiuli .

Editor information

Editors and Affiliations

  1. Division of General and Upper Gastrointestinal Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy

    Giovanni de Manzoni

  2. Unit of General Surgery and Surgical Oncology, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy

    Franco Roviello

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Degiuli, M., Baiocchi, G.L., Puca, L., Reddavid, R. (2022). Long-Term Survival and Follow-Up After Gastrectomy for Cancer. In: de Manzoni, G., Roviello, F. (eds) Gastric Cancer: the 25-year R-Evolution. Updates in Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-73158-8_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-73158-8_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-73157-1

  • Online ISBN: 978-3-030-73158-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation